Guardian Pharmacy Services, Inc. (GRDN) - Stock Analysis

Last updated: Sep 5, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

GRDN rose 14.4% over 21 sessions to a September 11 high. The company raised full-year guidance, expanded residents served by 8%, completed pharmacy-related acquisitions, and has a September 15 healthcare conference that could generate additional operating commentary.

Loading chart data...

Idea window: 9/11/2026 – 9/18/2026Sector: Healthcare

AI Analyst Overview

Last Price
$43.64
Market Cap
$2.76B
1D Return
-0.43%
YTD Return
+45.03%

Loading chart data...

Valuation Metrics

P/E
41.6
P/B
11.3
P/S
1.9
EV/EBITDA
24.3
Div Yield
—

Fundamental Analysis

7.0

Key Financial Insights: • Margin Expansion • Strong Cash Flow • Lower Leverage GRDN's improving margins, cash generation, liquidity, and lower leverage support fundamentals, but elevated valuation and working-capital exposure warrant caution.

ImprovingFundamentals
HighValuation

Price Behavior

6.0

Key Price Behavior Insights: • Four-day rebound • Near resistance • Elevated momentum Support Level: $38.80; $37.10 Resistance Level: $40.80–$41.50 GRDN's rebound is constructive but near-term extended; watch $40.80–$41.50 resistance for upside confirmation, with $38.80 and $37.10 as key supports.

bullish
cautious

Sentiment & News

7.0

Key News Insights: • EBITDA acceleration • Raised guidance • Nautilus acquisition Guardian Pharmacy posted stronger Q2 profitability, raised guidance, expanded its customer base and acquisition footprint, signaling positive growth momentum despite drug-pricing pressure.

EarningsGrowth
Expansion
AI

AI Summary

6.0
Neutral

GRDN has shifted into a margin-expansion and acquisition-execution story, with strong cash flow and low leverage supporting upside if its 10% EBITDA margin and roll-up synergies prove durable; however, its premium valuation leaves little room for IRA reimbursement pressure, weak revenue-per-resident conversion, or integration missteps, making confirmation of sustained margins and deal returns essential before adding exposure.

MarginExpansion
IntegrationRisk
Valuation
AI summary updated 6 days ago

Description

Guardian Pharmacy Services provides pharmacy and clinical medication services to residents of lower-acuity long-term care facilities across the United States, including assisted living, behavioral health facilities and group homes. The company pairs medication dispensing and administration with operational tools—such as dashboards built from its data warehouse—and programmatic offerings for facility clients. Guardian Pharmacy Services was founded in 2003 and is headquartered in Atlanta, Georgia.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Sep 11Sep 18GRDNGuardian Pharmacy Services, Inc.
GRDN rose 14.4% over 21 sessions to a September 11 high. The company raised full-year guidance, expanded residents served by 8%, completed pharmacy-related acquisitions, and has a September 15 healthcare conference that could generate additional operating commentary.
Active+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.